Corpus Intelligence IC Memo — COMANCHE COUNTY MEMORIAL HOSPITAL 2026-04-26 04:04 UTC
IC Memo — COMANCHE COUNTY MEMORIAL HOSPITAL
Investment Committee Memorandum | OK | 201 beds | Grade C | EBITDA uplift $22.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COMANCHE COUNTY MEMORIAL HOSPITAL

CCN 370056 | nan, OK | 201 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

COMANCHE COUNTY MEMORIAL HOSPITAL is a 201-bed safety-net/medicaid heavy in nan, OK with $304.2M in net patient revenue and a -7.9% operating margin. The hospital serves a payer mix of 34.3% Medicare, 28.4% Medicaid, and 37.3% commercial.

Thesis: Undervalued. Our ML models identify $22.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.9% to -0.5% (+736bps).

Net Revenue HCRIS$304.2M
Current EBITDA COMPUTED$-23.9M
Operating Margin COMPUTED-7.9%
Occupancy HCRIS62.7%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS24.1%
Distress Probability ML50.7%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
17
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -7.9% places it above the state median. Among 17 size-comparable peers (100-402 beds), the median margin is -4.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (100-402), prioritizing same-state peers. 17 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COMANCHE COUNTY MEMORIAL HOSPI (Target)OK201$304.2M-7.9%
MERCY HOSPITAL OKCOK344$674.3M10.5%
NORMAN REGIONAL HOSPITAL AUTHOOK322$540.7M-8.1%
INTEGRIS SOUTHWEST MEDICAL CENOK169$267.6M-13.5%
HILLCREST HOSPITAL SOUTHOK152$218.9M4.9%
SAINT FRANCIS HOSPITAL SOUTHOK104$198.3M34.4%
SAINT FRANCIS HOSPITAL MUSKOGEOK236$196.5M11.6%
MERCY HOSPITAL ARDMOREOK140$158.8M-1.1%
OSU MEDICAL CENTEROK119$142.7M-35.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $22.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.4M+210bp18mo
Cost to Collect4.5%2.5%$6.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.7M+122bp9mo
Clean Claim Rate88.0%96.0%$195K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.4M
Cost to Collect
$6.1M
Denial Rate Reduction
$6.0M
A/R Days Reduction
$3.7M
Clean Claim Rate
$195K
Total EBITDA Uplift$22.4M
Current EBITDA$-23.9M
+ RCM Uplift+$22.4M
Pro Forma EBITDA$-1.5M
Current Margin-7.9%
Pro Forma Margin-0.5%
WC Released (1x)$11.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-36.7M$66.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-36.7M$61.0M0.00x-100.0%
Bull Case9.0x11.0x$-33.1M$123.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-33.1M$124.4M0.00x-100.0%
Bear Case11.0x10.0x$-40.4M$-33.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-40.4M$-50.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (28.4%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 50.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 17 hospitals with 100-402 beds
  • Same-state prioritization (n=18)
  • Comp margins: P25=-24.3% / P50=-4.8% / P75=10.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.